All Stories
Follow
Subscribe to aap Implantate AG

aap Implantate AG

ots Ad hoc-Service: aap Implantate AG <DE0005066609> FDA clears for marketing new bone cement from aap subsidiary Coripharm

Berlin (ots Ad hoc-Service) -

Ad hoc-announcement edited and sent by DGAP. The sender is solely
responsible for the contents of this announcement.
FDA clears for marketing new bone
cement from aap subsidiary Coripharm
The aap-subsidiary Coripharm Medizinprodukte GmbH & Co, a
specialist for biomaterials, has achieved an important milestone in
its business field bone cements. The U.S. Food and Drug
Administration (FDA) has cleared for marketing the bone cement
VersaBond(r), developed by Coripharm GmbH & Co. KG for its US- sales
partner, the Orthopedic Division of Smith & Nephew, Inc. Coripharm
GmbH & Co. KG is a wholly-owned subsidiary of Berlin-based German
company aap Implantate AG. The bone cement is manufactured by
Coripharm GmbH & Co. KG in Dieburg, Germany. Smith & Nephew Inc. is
sole distributor in the U.S. and worldwide. In addition, the
US-company has integrated into its product portfolio as sole
distributor worldwide the MixOR(r) cementing technique, developed
exclusively by Coripharm GmbH & Co. KG.
VersaBond(r) bone cement is designed for use in joint
replacements, especially hip and knee replacements, when a prosthesis
has to be cemented. Cementing the prosthesis fixes the
artificial-implant parts mechanically, enabling the patient to put
weight or strain on the affected area right away.
Specially designed for use with VersaBond(r) bone cement,
Coripharm has developed a new vacuum cementing system. It is also
manufactured at Coripharm GmbH & Co. KG's production facilities
exclusively for Smith & Nephew, Inc.
aap Implantate AG, a leading German company in the biomedical
implant field, estimates the annual volume of the global market for
bone cement and cementing technique at EUR 300 mio.
If you have any queries, please contact: aap Implantate AG aap
Implantate AG Bruke Seyoum Alemu Gabriele Voßkühler Member of the
Board of Management Investor Relations Finance and Information
Technology Lorenzweg 5 Lorenzweg 5 12099 Berlin 12099 Berlin Tel: +49
(0)30 / 750 19-170 Tel: +49 (0)30 / 750 19-133 Fax: +49 (0)30 / 750
19-111 Fax: +49 (0)30 / 750 19-111
WKN:506660; Index: Listed:Neuer Markt Frankfurt; Freiverkehr in
Berlin, Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart
End
Internet: http://recherche.newsaktuell.de

Original content of: aap Implantate AG, transmitted by news aktuell

More stories: aap Implantate AG
More stories: aap Implantate AG